Virtu KCG Holdings’s Moleculin Biotech MBRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2017 Q2	$676K	Buy	4,015 +1,415	+54%	+$238K	0.02%	865
2017 Q1	$274K	Buy	+2,600	New	+$274K	0.01%	2029
2016 Q4	–	Sell	-129	Closed	-$66K	–	3621
2016 Q3	$66K	Buy	+129	New	+$66K	﹤0.01%	2720